Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TEAD3 | Q99594 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19065970 | 0.85 | L3MBTL1 (0.47) | L3MBTL1TSHREPHX2TDP1TEAD3 | |
| SCHEMBL9514922 | 0.85 | TSHR (0.47) | L3MBTL1TSHRTDP1HTTSMN1; SMN2 | |
| SCHEMBL29439954 | 0.84 | L3MBTL1 (0.46) | L3MBTL1TSHREPHX2TDP1TEAD3 | |
| SCHEMBL17746747 | 0.84 | PPARA (0.52) | L3MBTL1TDP1 | |
| SCHEMBL29033242 | 0.83 | L3MBTL1 (0.54) | L3MBTL1EPHX2TDP1 | |
| SCHEMBL30533272 | 0.83 | L3MBTL1 (0.54) | L3MBTL1EPHX2TDP1 | |
| SCHEMBL10782004 | 0.83 | L3MBTL1 (0.54) | L3MBTL1EPHX2TDP1 | |
| SCHEMBL30533275 | 0.83 | L3MBTL1 (0.54) | L3MBTL1EPHX2TDP1 | |
| SCHEMBL21677644 | 0.83 | L3MBTL1 (0.54) | L3MBTL1EPHX2TDP1 | |
| SCHEMBL10864410 | 0.83 | L3MBTL1 (0.45) | L3MBTL1TSHREPHX2TDP1TEAD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160058682-A1 | COMPOSITION CONTAINING A DIBENZOYLMETHANE SCREENING AGENT AND A HYDROPHILIC OR WATER-SOLUBLE MEROCYANIN UV-SCREENING AGENT; PROCESS FOR PHOTOSTABILIZING THE DIBENZOYLMETHANE SCREENING AGENT | OREAL (FR) | 2016-03-03 | — | — | US | disclosed |
| US-9162976-B2 | Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent | L'OREAL (FR) | 2015-10-20 | — | — | US | disclosed |
| US-20130058990-A1 | COMPOSITION CONTAINING A DIBENZOYLMETHANE SCREENING AGENT AND A HYDROPHILIC OR WATER-SOLUBLE MEROCYANIN UV-SCREENING AGENT; PROCESS FOR PHOTOSTABILIZING THE DIBENZOYLMETHANE SCREENING AGENT | L'OREAL (FR) | 2013-03-07 | — | — | US | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160058682-A1 | COMPOSITION CONTAINING A DIBENZOYLMETHANE SCREENING AGENT AND A HYDROPHILIC OR WATER-SOLUBLE MEROCYANIN UV-SCREENING AGENT; PROCESS FOR PHOTOSTABILIZING THE DIBENZOYLMETHANE SCREENING AGENT | CRYZ, MSH6, TYR | L3MBTL1 4616/4885TSHR 4054/4885EPHX2 315/4885 |
| US-20130058990-A1 | COMPOSITION CONTAINING A DIBENZOYLMETHANE SCREENING AGENT AND A HYDROPHILIC OR WATER-SOLUBLE MEROCYANIN UV-SCREENING AGENT; PROCESS FOR PHOTOSTABILIZING THE DIBENZOYLMETHANE SCREENING AGENT | CRYZ, MSH6, TYR | L3MBTL1 4623/4885TSHR 4160/4885EPHX2 364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.